2 Years Later, Cannabis 2.0 Isn't Saving Canopy Growth

This Canadian pot company was the first to impress customers with cannabis derivatives, so what went wrong?

Derivatives are additional recreational products that Canada legalized in October 2019 as part of "Cannabis 2.0" legalization. These products garnered a lot of consumers' attention. Thus, Canadian pot companies were eager to launch them. Canopy Growth (NASDAQ:CGC) was the one to jump at the opportunity. 

Canopy Growth had an early mover advantage in the Canadian medical cannabis market. It first started selling cannabis oil in the fourth quarter of fiscal 2016.